Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers find BRCA1 tumor suppression nullified by cyclin D1

08.08.2005


Study results reaffirm cyclin D1 as a candidate target for molecular therapeutic control of breast tumor development.



For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases arise from these genetic miscues, about half of which are linked to the abnormal functioning of BRCA1.

But now scientists have discovered that a protein called cyclin D1, grossly overproduced in about half of all cases of breast cancer, can also disrupt BRCA1’s normal role as a cancer inhibitor. They found that because cyclin D1 binds to the same estrogen receptor as does BRCA1, when the cell is flooded with cyclin D1, BRCA1 is unable to activate a pathway that stops cancer development.


The results reaffirm cyclin D1 as a candidate target for molecular therapeutic control of breast tumor development.

"We’ve previously shown that if you have a gene therapy vector that blocks cyclin D1 in breast tumors, you can block the growth of those tumors," said Richard Pestell, M.D., Ph.D., director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center and senior author of the paper published in the August 1 issue of Cancer Research.

Also part of the Georgetown University research team were Chenguang Wang, Ph.D., assistant professor at the Lombardi Comprehensive Cancer Center and the lead author of the article, and Georgetown Professor of Oncology Eliot M. Rosen, a co-investigator on the study, which was funded in part by a grant from the Department of Defense. Participating in the research from the Georgetown oncology department were Saijun Fan, Zhiping Li, Maofu Fu, Mahadev Rao, Yongxian Ma, and Chris Albanese.

This paper, Pestell said, identifies the mechanism by which cyclin D1 nullifies one activity of the tumor suppressor BRCA1.

"Cyclin D1 is a collaborative oncogene and is sufficient for the induction of breast tumorogenesis in transgenic mice," he said. "This protein blocks the functional activity of the BRCA1 tumor suppressor. The science reported in this paper describes an important oncogene/tumor suppressor interaction."

The tumor-promoting action of various oncogenic sources upregulating expression of cyclin D1 converge at the common binding site on the estrogen receptor alpha (ERa) that is shared by both cyclin D1 and BRCA1. This research builds on a major discovery by the laboratory by Dr. Rosen, showing that BRCA1 interacts with, and inhibits the activity of ERa, the protein that transduces the growth signal of estrogen.

"This may help explain why the cyclin D1 gene and the BRCA1 gene are important primarily in hormone responsive cancers," Pestell said. "The interaction occurs at the level of the ERa hormone receptor."

Cyclin D1 is a protein produced by cells and routinely functions in events that promote cell division. In cancer, cyclin D1 is regulated and abundantly overexpressed by a number of factors that promote tumor growth, such as the oncogenes ErB2, src, and ras. In more than half of human patients with breast cancer, tumor cells produce as much as eight times the amount of cyclin D than healthy breast cells.

Cyclin D1 interferes with BRCA1 function because the two proteins both bind to the same spot on ERa, an important protein that governs cell proliferation properties in both healthy and cancerous cells. In healthy cells, BRCA1 binds to ERa to restrain and control estrogen-target genes that promote cell division. In cancer cells, however, cyclin D1 occupies the binding site on the ERa to promote proliferation. The abundance of cyclin D1 pre-empts BRCA1 binding to the estrogen receptor and negates the tumor suppressor role of the BRCA1 gene product.

In addition to their Georgetown research colleagues, Wang and Pestell conducted their research in concert with Michael Lisanti, Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, N.Y.; Benita Katzenellenbogen, Departments of Molecular and Integrative Physiology and Cell and Structural Biology, University of Illinois and College of Medicine, Urbana, Ill.; Peter J. Kushner, Metabolic Research Unit, University of California-San Francisco School of Medicine, San Francisco, Calif.; and Barbara Weber, Department of Molecular Genetics, University of Pennsylvania, Philadelphia, Pa.

Laura Cavender | EurekAlert!
Further information:
http://www.georgetown.edu

More articles from Life Sciences:

nachricht Transport of molecular motors into cilia
28.03.2017 | Aarhus University

nachricht Asian dust providing key nutrients for California's giant sequoias
28.03.2017 | University of California - Riverside

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>